Innova Partnerships Launches Commercialisation Hub in South East England
Jan 07, 2016
To mark their 10th year of operations, Innova Partnerships Ltd is starting 2016 with the appointment of a new Business Development Director and the opening of a new commercialisation hub in South East England.
Innova Partnerships Ltd builds and grows life science enterprises through partnering, investment and a range of commercialisation services.
The company has appointed Dr Paul Meakin as Director of Business Development. Paul has a strong background in commercialisation and sales with companies such as Forsite Diagnostics and most recently worked with Knowledge Transfer Network in the agri-tech and early-stage investment teams.
He will head up Innova Partnerships’ presence in strategically important markets including London, Cambridge and Oxford. These will be served from a new location in Bedford.
Entering their 10th year, Innova Partnerships Ltd have made this move in response to increased demand and a growing customer base in these regions.
Innova CEO Prof Steve Howell is currently visiting professor of King’s College London and the company has a broad client base operating in key life science clusters such as Oxford and Cambridge. Innova Partnerships Ltd also drove formation and commercialisation of Reminova Ltd, a dental spin out from King’s College London in 2014.
Steve commented, “We are excited to build upon our presence in a region that is important in shaping global life sciences and aligned to the work we undertake at Innova Partnerships. We look forward to working with Paul to build a heightened presence and becoming embedded in the local life science ecosystems of South East England".
Vitamica Announce Successful First Round of Funding
- Oct 10, 2018
Innova Partnerships Appointed by Invest Northern Ireland to Support Irish Company Growth
- Jun 01, 2018
Innova Partnerships’ Latest Portfolio Company, Vitamica Ltd, Spun Out of the University of Bristol
- Apr 20, 2018
Biotangents Secures £326,000 in Equity Finance
- Dec 21, 2017
Biotangents; Primed for Success
- Oct 19, 2017